[Experimental study of some pharmacodynamic properties of magnesium 2-pyrrolidone-5-carboxylate].
D000700:Analgesics; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D003913:Dextroamphetamine / Q000037:antagonists & inhibitors; D007928:Lethal Dose 50; D008274:Magnesium / Q000494:pharmacology* / Q000633:toxicity; D008297:Male; D051379:Mice; D003473:Neuromuscular Nondepolarizing Agents; D010276:Parasympatholytics; D011760:Pyrrolidinones / Q000494:pharmacology*; D011761:Pyrrolidonecarboxylic Acid / Q000494:pharmacology* / Q000633:toxicity; D011817:Rabbits; D051381:Rats; D012119:Respiration / Q000187:drug effects; D012890:Sleep / Q000187:drug effects
D000700:Analgesics; D003473:Neuromuscular Nondepolarizing Agents; D010276:Parasympatholytics; D011760:Pyrrolidinones; D008274:Magnesium; D011761:Pyrrolidonecarboxylic Acid; D003913:Dextroamphetamine
Etude expérimentale de quelques propriétés pharmacodynamiques du pyrrolidone-2 carboxylate-5 de magnésium